News Conference News STS 2019 TAVR More Prevalent in Highly Competitive Hospital Markets Yael L. Maxwell February 04, 2019
News Conference News STS 2019 Past SAVR Outcomes Matter More Than Volume in Determining Future Performance Yael L. Maxwell January 31, 2019
News Conference News STS 2019 TAVR Outcomes Dependent on SAVR Hospital Volumes Yael L. Maxwell January 28, 2019
News Conference News AHA 2018 Complications Following TAVR Are Going Down, US Data Show Yael L. Maxwell November 20, 2018
News Conference News TCT 2018 Prosthetic Valve Endocarditis Rate Similarly Low for TAVR vs SAVR TCT Daily Staff September 28, 2018
News Conference News PCR London Valves 2018 No Symptoms? Some AS Patients Undergo Valve Replacement Despite Lack of Clinical Indication Shelley Wood September 12, 2018
News Conference News PCR London Valves 2018 Ten-Year Trends in the UK Show TAVR Rates Rising but SAVR Holding Steady Shelley Wood September 11, 2018
News Conference News EuroPCR 2018 NOTION: TAVR in Low-Risk Patients Maintains Its Momentum Through 6 Years Caitlin E. Cox May 24, 2018
News Conference News ACC 2018 Urgent/Emergent TAVR: Risky but Rewarding, TVT Registry Data Hint Caitlin E. Cox March 19, 2018
News Conference News ACC 2018 NOTION: 5-Year Outcomes for TAVR Match SAVR in Low-Risk Patients Shelley Wood March 10, 2018
News Conference News TCT 2017 TAVR Beats Out SAVR, at Least In-Hospital, for Patients With Prior CABG Ashley Lyles November 08, 2017
News Conference News TCT 2017 A-fib Signals Worse Prognosis After Aortic Valve Replacement in Intermediate-Risk Patients Todd Neale November 08, 2017
News Conference News PCR London Valves 2017 Valve Deterioration and Durability Definitions Now Standardized in New Guide Shelley Wood September 25, 2017
News Conference News ESC 2017 European Societies Issue New Valvular Heart Disease Guidelines, With Important Shifts Shelley Wood August 27, 2017
News Conference News EuroPCR 2017 More Early Stroke With SAVR Than TAVR in SURTAVI Shelley Wood May 18, 2017
News Conference News EuroPCR 2017 TAVR Durability: Some Reassurances From CoreValve Trials Out to 9 Years Caitlin E. Cox May 17, 2017
News Conference News ACC 2017 Leaflet Thrombosis Common After Aortic Valve Implant, More So in TAVR Than in Surgery Michael O'Riordan March 19, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017
News Conference News AHA 2016 “Huge Shift” Favoring Interventions in Aortic Stenosis Care May Still Omit Many Elderly Patients Yael L. Maxwell November 21, 2016